6 Biotech Stocks Short Sellers Are Avoiding
Contextuall | Dec 14, 2012 03:14AM ET
:
All of the Biotech companies mentioned below have been boosted by short sellers covering their positions over the last month.
Average Weekly Returns:
Average 1-Week Return of All Stocks Mentioned Below: 2.38%
Average 1-Month Return of All Stocks Mentioned Below: 5.38%
Analysis of List Alpha:
Number of Stocks in This List Generating Excess Return vs. SP500 (Beta Adjusted Over Last Week): 3 out of 6 (50.0%)
Number of Stocks in This List Generating Excess Return vs. SP500 (Beta Adjusted Over Last Month): 2 out of 6 (33.33%)
Chart: Distribution of 1-Week Returns For All Stocks Mentioned Below
Chart: Distribution of 1-Month Returns For All Stocks Mentioned Below
1. Dendreon Corp. (DNDN): Engages in the discovery, development, and commercialization of therapeutics to enhance cancer treatment options for patients. Shares shorted currently at 45.68M vs. 47.16M shares shorted in the previous month (a decrease in short interest representing 1.01% of total float).
2. MannKind Corp. (MNKD): Focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer. Shares shorted currently at 25.51M vs. 27.11M shares shorted in the previous month (a decrease in short interest representing 1.27% of total float).
3. Cell Therapeutics, Inc. (CTIC): Engages in the development, acquisition, and commercialization of drugs for the treatment of cancer. Shares shorted currently at 1.91M vs. 2.39M shares shorted in the previous month (a decrease in short interest representing 1.37% of total float).
4. Threshold Pharmaceuticals Inc. (THLD): Engages in the discovery and development of drugs targeting the microenvironment of solid tumors for patients living with cancer. Shares shorted currently at 7.18M vs. 7.87M shares shorted in the previous month (a decrease in short interest representing 1.53% of total float).
5. Affymax, Inc. (AFFY): Engages in the development of drugs for the treatment of serious and life-threatening conditions. Shares shorted currently at 3.51M vs. 4.22M shares shorted in the previous month (a decrease in short interest representing 2.22% of total float).
6. Momenta Pharmaceuticals Inc. (MNTA): Momenta Pharmaceuticals, Inc., a biotechnology company, specializes in the in the characterization and process engineering of complex molecules. Shares shorted currently at 3.01M vs. 4.44M shares shorted in the previous month (a decrease in short interest representing 3.84% of total float).
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.